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Abstract
Genome editing occurs in the context of chromatin, which is heterogeneous in structure and
function across the genome. Chromatin heterogeneity is thought to affect genome editing
efficiency, but this has been challenging to quantify due to the presence of confounding
variables. Here, we develop a method that exploits the allele-specific chromatin status of
imprinted genes in order to address this problem in cycling mouse embryonic stem cells
(mESCs). Because maternal and paternal alleles of imprinted genes have identical DNA
sequence and are situated in the same nucleus, allele-specific differences in the frequency
and spectrum of mutations induced by CRISPR-Cas9 can be unequivocally attributed to epi-
genetic mechanisms. We found that heterochromatin can impede mutagenesis, but to a
degree that depends on other key experimental parameters. Mutagenesis was impeded by
up to 7-fold when Cas9 exposure was brief and when intracellular Cas9 expression was low.
In contrast, the outcome of mutagenic DNA repair was unaffected by chromatin state, with
similar efficiencies of homology-directed repair (HDR) and deletion spectra on maternal and
paternal chromosomes. Combined, our data show that heterochromatin imposes a perme-
able barrier that influences the kinetics, but not the endpoint, of CRISPR-Cas9 genome
editing and suggest that therapeutic applications involving low-level Cas9 exposure will be
particularly affected by chromatin status.
Author summary
Genomic imprinting is a developmental process through which either the maternally or
paternally derived allele of a gene is epigenetically silenced. Imprinting has served as a
model system to understand the mechanisms through which chromatin modifications
can influence transcriptional regulation; comparisons between active and repressed alleles
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in the same cell nucleus provide an internal control for the effects of DNA sequence prop-
erties and exposure to trans-regulators (elements that modify distant genes). Here, we
have exploited these features in order to understand how chromatin modifications influ-
ence genome editing with the clustered regularly interspaced short palindromic repeats
(CRISPR)-CRISPR-associated protein 9 (Cas9) system. By comparing the frequency and
spectrum of Cas9-induced genome edits on maternal versus paternal alleles of imprinted
genes, we discovered experimental conditions that determine whether chromatin modifi-
cations have a large or small effect on the outcome of genome editing procedures. We
show that chromatin state does not affect the size of deletions and insertions or their rela-
tive frequency compared to precise genome edits specified by an oligonucleotide donor
template. However, repressed chromatin inhibits the rate at which mutations form, partic-
ularly when the intracellular concentration of Cas9 is low. At longer exposure times,
mutation frequencies on repressed versus active alleles are similar. Collectively, our data
suggest that chromatin status affects the kinetics but not the endpoint of genome editing
experiments.
Introduction
Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated pro-
tein 9 (Cas9) is an RNA-guided endonuclease involved in bacterial adaptive immunity, which
has been repurposed as a highly efficient tool for eukaryotic genome editing [1–3]. In its natu-
ral form, Cas9 protein associates with a duplex of two RNA molecules: the CRISPR RNA
(crRNA), which recognises a short section of target DNA (the ‘protospacer’), and a trans-
activating crRNA, which acts as a scaffold to link the crRNA and Cas9 endonuclease. Most
genome editing applications use a single guide RNA molecule (sgRNA) resulting from an engi-
neered fusion of these two components. After target DNA cleavage, mutations arise through
the action of cellular DNA repair pathways. Nonhomologous end joining (NHEJ; including
both classical and microhomology-mediated pathways) can yield short insertions and dele-
tions (InDels) suitable for gene knockout, whereas homology-directed repair (HDR) pathways
utilise exogenous donor templates to introduce precise sequence changes.
It is well established that genetic properties of the genomic target site and sgRNA molecule
have a significant effect on the efficiency of CRISPR mutagenesis [4–6]. However, Cas9, being
prokaryotic in origin, did not evolve to cope with the complex chromatinised environment of
the eukaryotic genome. Despite prior studies in this area [4,7–15], the extent to which epige-
netic properties of the target site—including DNA and histone modifications—influence
mutation frequency and DNA repair outcome remains incompletely understood. Stably posi-
tioned nucleosomes act as a barrier to Cas9 binding and function on synthetic chromatin
fibres [7,8,11], and in vivo [7,15], yet catalytically dead Cas9 (dCas9) can open previously inac-
cessible regions of chromatin [16,17]. It has been reported that some sgRNAs show reduced
activity within heterochromatin whereas others do not [13,14]. The reasons behind this para-
dox are unclear but presumably involve other experimental variables that modify the influence
of chromatin on CRISPR activity. Furthermore, it is widely accepted that double strand break
(DSB) repair is influenced by the chromatin environment in which DSBs arise [18–22], and
DSB repair is central to the mechanism of genome editing [23,24]. However, it is unclear
whether preexisting epigenetic properties of the target site impact upon the specific sequence
changes that arise following Cas9 cleavage.
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Genomic imprinting is a natural epigenetic process in which either the maternal or pater-
nally derived copy of a gene is transcriptionally silenced. Essential regulatory elements within
imprinted domains called ‘imprinting control regions’ undergo differential methylation at
CpG dinucleotides during male and female gametogenesis. This leads to the establishment of
monoallelic domains of heterochromatin in the early embryo that are maintained throughout
somatic development [25]. These imprinted alleles carry all known hallmarks of constitutive
heterochromatin, including post-translational histone modifications (H3K9me3, H4K20me3,
histone hypoacetylation) and heterochromatin binding proteins (HP1γ) [26].
Genomic imprinting has provided numerous insights into mechanisms of transcriptional
regulation [27–30]. Because active and silent alleles of imprinted loci have an identical DNA
sequence, chromosomal position, and potential exposure to diffusible regulators, allele-specific
chromatin modifications must be sufficient to account for their allele-specific expression [31].
Based on this principle, we postulated that genomic imprinting could be used to provide new
insights into the influence of chromatin modifications on targeted mutagenesis.
Results
Mouse embryonic stem cell (mESC) lines were derived from male F1 hybrid blastocysts of
inter-subspecies crosses between (C57BL6/J [B6]) and the Mus musculus molossinus inbred
strain JF1 (Fig 1A). These cells are heterozygous for strain-specific single nucleotide polymor-
phisms (SNPs) [32], which serve as genetic markers that distinguish maternal and paternal
chromosomes. To control for possible genetic effects on mutagenesis arising from SNPs, we
derived mESCs from reciprocal crosses (B6 female × JF1 male [B×J], and JF1 female × B6 male
[J×B]) and used both cell lines in parallel wherever possible. Although mESCs show globally
reduced CpG methylation compared to primary somatic cells, the effects on imprinted regions
were minimised by using male (XY) cells cultured in serum-free conditions. Unless otherwise
stated, cells were cultured in the presence of pharmacological inhibitors of GSK3β but not
MEK signalling [33,34].
We targeted three maternally imprinted CpG islands: KvDMR1 (hereafter referred to as
KvDMR, Fig 1B, S1A Fig), Impact (S2A Fig), and Inpp5f_v2 (S3A Fig). To determine whether
these loci had distinct epigenetic configurations on maternal and paternal alleles in B×J and
J×B mESCs, we performed allele-specific DNase-I hypersensitivity assays (S1B, S2B and S3B
Figs) as well as allele-specific chromatin immunoprecipitation (ChIP) experiments for
H3K9me3 and H4K20me3 (Fig 1C, S1C, S1D, S2C, S2D, S3C and S3D Figs). In each case,
paternally derived alleles were substantially more sensitive to DNase-I digestion, whereas
maternal alleles were highly enriched for heterochromatin marks. Nonetheless, in some cases,
loss of imprinting (LOI) was evident from incomplete allelic enrichment of histone modifica-
tions (S3D Fig) and incomplete depletion of paternal alleles by DNase-I (S3B Fig). During sub-
sequent editing experiments, we therefore quantified CpG methylation levels as a biomarker
of LOI at the target site in mock-transfected cells (Fig 1D).
We designed three different sgRNAs to target protospacer sequences within KvDMR (Fig
1B, S1A Fig). mESCs were transfected with Cas9 and individual sgRNAs expressed from plas-
mid pX459v2 [35], together with a single-stranded oligodeoxynucleotide (ssODN) donor tem-
plate that introduced point mutations to prevent re-cutting following HDR. Transfected cells
were selected in puromycin and collected as a pool 96 hours after transfection. Editing was
quantified by Illumina sequencing of PCR amplicons spanning both the site of cleavage and
an allelic SNP (Fig 1A and S1A Fig, for detailed experimental protocols see Materials and
methods). This allowed the outcome of mutagenic repair to be determined, at the nucleotide
level, separately on maternal and paternal chromosomes.
Heterochromatin delays CRISPR mutagenesis
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We first compared the frequency of all edits, including InDels and point mutations intro-
duced from ssODN donors, on maternal versus paternal alleles. All three sgRNAs yielded
more mutations on the active paternal allele compared to the repressed maternal allele (Fig
2A and 2B), whereas a control, nonimprinted locus (NCAPH) showed no such allelic bias
(Fig 2C and 2D). The effect of imprinted chromatin was subtle in this context: 1.1- to
Fig 1. Imprinted chromatin as a model system to quantify epigenetic influences on genome editing. (A) Schematic outlining the
experimental workflow. Throughout the text, F1 hybrid cell lines are depicted with the maternal strain denoted before the paternal strain
(i.e., In B×J: B is maternal and J paternal). sgRNAs are designed to cleave approximately 40–100 bp from a heterozygous SNP within
imprinted chromatin (open and closed circles). MiSeq amplicons span both the SNP and site of mutation, which allows simultaneous
assessment of genome editing outcome and parental allele at high-throughput. (B) Top: schematic showing the imprinted mouse Kcnq1
gene including H3K9me3 ChIP and DNase-I–seq data from mESCs available through EncODE (ENCSR000CFZ, GSM1014187) (bottom).
Higher-resolution view of the KvDMR imprinted CpG island within Kcnq1, showing the position of three sgRNAs used in panel E. (C)
Allele-specific enrichment of H3K9me3 and H4K20me3. PCR fragments spanning the target sites of sgKvDMR#2 and #3 were amplified
from input, or ChIP DNA prior to Sanger sequencing across an allelic SNP. gDNA = genomic DNA from purebred mice. (D) Example of
CpG methylation data from the KvDMR locus. Bisulphite-converted gDNA was subjected to Illumina amplicon sequencing across a region
spanning 13 CpG dinucleotides (S1A Fig), and reads were classified according to the proportion of nonconverted (methylated) CpGs. The
black dashed line indicates the expected level of methylation across all alleles when imprinting is completely maintained (50%). In
subsequent editing experiments, the percentage of hypermethylated (>80%) strands is reported together with histograms showing allele-
specific mutation frequency. Quantitative data underlying panel D are provided in S1 Data, and details of MiSeq libraries including SRA
accessions are provided in S2 Data. ChIP, chromatin immunoprecipitation; gDNA, genomic DNA; HDR, homology-directed repair;
mESC, mouse embryonic stem cell, NHEJ, nonhomologous end joining; sgRNA, single guide RNA; SNP, single nucleotide polymorphism;
SRA, Sequence Read Archive; ssODN, single-stranded oligodeoxynucleotide.
https://doi.org/10.1371/journal.pbio.2005595.g001
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1.6-fold (Fig 2A and 2B), even in B×J cells in which imprinting was completely maintained
(Fig 1D).
To ensure that the observed bias in allele-specific mutation frequency could be attributed to
chromatin modifications, we took advantage of the stochastic LOI reported to occur in mESCs
[33,34,36]. In a series of six triplicate mutagenesis experiments targeting three imprinted loci
(sgKVDMR1, sgImpact, sgInpp5f_v2) in two mESC lines, we observed a significant correlation
between the degree of imprinted CpG methylation in mock-transfected cells and the degree of
allele-specific mutation bias (r = 0.82, p< 0.05, Fig 3A). To experimentally induce LOI, a B×J
cell line was cultured to high passage (p23) in the presence of MEK inhibitors (‘2i’) and vita-
min C, which have been reported to induce global hypomethylation in mESCs [33,34,37]. CpG
methylation was unaffected at the KvDMR locus, slightly reduced at Impact, and completely
lost at Inpp5f_v2 in late passage compared to early passage cells (Fig 3C). Accordingly, allele-
specific mutation bias was lost at Inpp5f_v2 but not at the KvDMR or Impact target sites
Fig 2. Lower mutation frequency on silenced alleles following 96-hour exposure. (A) Allele-specific mutation frequencies for KvDMR
sgRNAs #1–3 in cells harvested 96 hours post transfection, following selection of transfectants in puromycin. Error bars represent SD of
three biological replicates; p-values denote two-tailed paired t tests of difference between maternal and paternal alleles. �p< 0.05,
��p< 0.01, ���p< 0.001. In this, and subsequent figures, the percentage of hypermethylated alleles in mock-transfected cells is shown
above the histogram to indicate the degree of imprinting at the time of editing. (B) Stacked histograms show the allelic mutation bias in
each experimental replicate. (C, D) Allele-specific mutation frequencies from experiments using an sgRNA (sgNCAPH) targeting a
nonimprinted locus, presented as described in panels A and B. Quantitative data underlying all panels are provided in S1 Data, and
details of MiSeq libraries including SRA accessions are provided in S2 Data. Mat, maternal; ND, methylation analysis not done; Pat,
paternal; sgRNA, single guide RNA; SRA, Sequence Read Archive.
https://doi.org/10.1371/journal.pbio.2005595.g002
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(Fig 3D and 3E). This shows that chromatin modifications are sufficient to influence the
frequency of mutations induced by CRISPR-Cas9 on identical target sites in the same cell
nucleus, but the effects are typically subtle (<2-fold) in cells harvested 96 hours following plas-
mid transfection.
We next considered whether common experimental variables affect the degree to which
modified chromatin impedes mutagenesis, reasoning that CRISPR might less efficiently over-
come the heterochromatin barrier when the intracellular concentration of Cas9 is low [38]. To
test this hypothesis, KvDMR sgRNA#3 was expressed from plasmid pX458, in which Cas9 is
Fig 3. Allele-specific mutation bias is caused by allele-specific chromatin modifications. (A) The degree of methylated alleles
correlates with allele-specific mutation bias across three imprinted target sites (sgInpp5f_v2, sgKvDMR1, sgImpact) in two mESC
lines. Each point represents the mean enrichment of mutations on paternal alleles over biological triplicate editing experiments (y-
axis) and a single CpG methylation measurement from mock-transfected cells (x-axis). (B) Schematic illustrating the derivation of
high-passage cells in order to induce LOI. Media composition (1i, 2i) and cell culture protocols are detailed in Materials and methods.
(C) CpG methylation levels at three imprinted loci in low- and high-passage mESCs (B×J only) following mock transfection. Note that
only the Inppf5_v2 locus has undergone extensive demethylation during culture. (D) Allele-specific mutation frequencies in low-
versus high-passage cells. Error bars represent SD (n = 3) Transfectants were not selected in these experiments, which accounts for the
lower overall mutation frequency relative to Fig 2. Transfection was also less efficient in high-passage cells. (E) Stacked histograms
show the allelic mutation bias in each experiment. Asterisks denote p-values for unpaired t tests on the fold-difference between
mutation frequencies on maternal and paternal alleles in low- compared to high-passage cells. ���p< 0.001. Quantitative data
underlying panels A, C, D, and E are provided in S1 Data, and details of MiSeq libraries including SRA accessions are provided in S2
Data. LOI, loss of imprinting; mESC, mouse embryonic stem cell; SRA, Sequence Read Archive.
https://doi.org/10.1371/journal.pbio.2005595.g003
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fused to enhanced green fluorescent protein (eGFP) via a self-cleaving 2A peptide. eGFP levels
therefore serve as a reporter of Cas9 translation (Fig 4A). Flow cytometry revealed that Cas9
translation levels were highly variable between cells at 24 hours post transfection (Fig 4B).
Cells were purified by fluorescence-activated cell sorting (FACS) into three categories based
on eGFP fluorescence and then collected either immediately (24 hours, S4 Fig) or following an
additional 3 days in culture (Fig 4). B×J cells expressing Cas9 at low levels showed a profound
(5.3-fold) reduction in mutation frequency on the silent maternal compared to the active
paternal allele after 4 days of exposure (Fig 4C). At intermediate levels of Cas9-eGFP expres-
sion, the mutational bias was moderate (2.6-fold), whereas high expression yielded only subtle
differences between alleles (approximately 1.2-fold) (Fig 4C). J×B cells showed the same trend,
but mutations on the maternal allele were more frequent, consistent with approximately 30%
LOI in this cell line (Fig 4C). Heterochromatin therefore impedes mutagenesis to a greater
extent when the intracellular concentration of Cas9 is low.
Single particle tracking experiments have shown that the efficiency of target searching by
dCas9 is reduced within heterochromatin [9]. Whether this impacts upon mutagenesis with
Cas9 nuclease was not tested. To determine whether heterochromatin delays mutation kinet-
ics, we initially targeted the Impact imprinted locus (S2 Fig), using a highly active sgRNA
(sgImpact) that yielded similar frequencies of mutation on maternal and paternal alleles after
96 hours of exposure (S2F Fig). B×J cells were collected at 4-hour intervals following transfec-
tion, after which allele-specific mutagenesis was quantified as described above (Fig 5A). As
expected, the frequency of mutations across both alleles increased steadily from 8 hours to 48
hours following transfection, but mutations were more skewed towards the active paternal
allele at earlier compared to later time points (Fig 5B). Using sgRNAs targeting two additional
imprinted loci (sgKvDMR#1 [S1 Fig] and sgInpp5f_v2 [S3 Fig]), we observed stronger skewing
towards allelic target sites within euchromatin at early (16-hour) compared to later (96-hour)
time points (Fig 5C–5F). This effect was most striking in cells exposed to high concentrations
of Cas9, for which a large majority (78%) of mutations present in euchromatin following 96
hours of exposure were found to occur within the first 24 hours (Fig 5G, S4 Fig). Within het-
erochromatin, only 23% of mutations present at 96 hours had occurred by this earlier time
point (Fig 5G, S4 Fig).
Allele-specific ChIP experiments were conducted to quantify dCas9 occupancy after target-
ing to the Impact and KvDMR imprinted loci (S5A Fig). This revealed an approximately 2-fold
enrichment on euchromatic alleles in both cases (S5B and S5C Fig). Similar levels of enrich-
ment for the euchromatic allele were evident from 8 hours post transfection, substantially
before the majority of mutations arise (Fig 5B), through to 96 hours. We conclude that hetero-
chromatin impairs the kinetics of mutagenesis by inhibiting Cas9 occupancy (S5 Fig), and to a
degree that depends on the level of intracellular Cas9 expression (Fig 4). However, target sites
within heterochromatin ultimately reach similar frequencies of mutation upon sustained
CRISPR exposure (Fig 5).
The repair of DSBs induced by Cas9-independent routes is thought to be influenced by the
preexisting chromatin environment at the site of cleavage [18,20–22]. However, whether DNA
accessibility and/or epigenetic modification of DNA and histone proteins can influence the
outcome of CRISPR mutagenesis, particularly the frequency of InDels arising via NHEJ versus
precise edits templated by exogenous nucleic acid donors (HDR), is not known. Imprinted
genes provide an ideal system with which to address this question.
For five sgRNAs targeting imprinted heterochromatin, mutational profiles were calculated
separately from sequencing reads originating from maternal (repressed) versus paternal
(active) alleles (Materials and methods). No consistent allelic biases were evident in the ratio of
InDels versus HDR-derived edits at 4 days post transfection (Fig 6A), but the rate of HDR
Heterochromatin delays CRISPR mutagenesis
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Fig 4. Heterochromatin impedes genome editing in a Cas9-concentration–dependent manner. (A) Schematic outlining the
experimental workflow. After FACS, cells were either harvested immediately (S4 Fig) or cultured for an additional 72 hours (this figure).
(B) Flow cytometry profiles show widely variable expression of Cas9-2A-eGFP at 24 hours following transfection with guide gKvDMR#3
expressed from pX458 (see panel A). (C) Allele-specific mutation analysis within cell populations expressing different levels of Cas9,
FACS purified 24 hours post transfection using the gating scheme in panel B and then cultured for an additional 72 hours before
harvesting. Allelic differences are less pronounced in J×B cells due to partial loss of imprinted heterochromatin on maternal alleles in this
cell line. Error bars represent SD of three biological replicates. (D) Stacked histograms show the allelic mutation bias in each experiment.
The percentage of methylated strands was measured in mock-transfected cells without selection for Cas9 expression level. One-way
ANOVA was conducted using fold-difference between mutation frequencies on maternal versus paternal alleles, to assess whether this
was affected by Cas9 expression level. Significant differences were found in both cell lines (p< 0.001). Asterisks denote p-values for
Tukey’s HSD test on the specified pairwise comparisons. �p< 0.05, ��p< 0.01. Quantitative data underlying panels C and D are provided
in S1 Data, and details of MiSeq libraries including SRA accessions are provided in S2 Data. Cas9, CRISPR-associated protein 9; eGFP,
enhanced green fluorescent protein; FACS, fluorescence-activated cell sorting; GFP, green fluorescent protein; HSD, honest significant
difference; RFP, red fluorescent protein; SRA, Sequence Read Archive; ssODN, single-stranded oligodeoxynucleotide.
https://doi.org/10.1371/journal.pbio.2005595.g004
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Fig 5. Heterochromatin impairs the kinetics of CRISPR mutagenesis. Schematic depicting the experimental workflow for the time course
experiment in panel B. (B) Overlaid line graphs depict total mutation rates (black solid line, right y-axis) and fold-enrichment for mutations on the
euchromatic paternal allele (green dashed line, left y-axis) over time using sgImpact targeting the imprinted Impact locus (S2 Fig) in B×J cells. Error
bars represent SD of three biological replicates. Transfected cells were not selected in this experiment. (C, E) Allele-specific mutation frequencies at
16 and 96 hours post transfection for experiments using an sgRNA targeting KvDMR (sgKvDMR#1; S1A Fig). Error bars represent SD (n = 3). (D,
F) Stacked histograms show the allelic mutation bias in each experiment. Asterisks denote p-values for unpaired t tests on the fold-difference
between maternal and paternal allele mutation frequencies following brief (16-hour) compared to long (4-day) exposure high-passage cells.
���p< 0.001. (G) Pie charts show mutation frequencies observed 24 hours post transfection, expressed as a percentage of the mutation frequency in
cells collected after 96 hours. Data are derived from the experiment described in Fig 4 and S4 Fig, with mutation frequencies broken down by both
parental allele and Cas9 expression level. Experiments used sgKvDMR#3 in B×J cells collected either immediately after sorting on Cas9-2A-eGFP
(24 hours) or after an additional 72 hours in culture. CIs indicate SD (n = 3 biological replicate transfections). Quantitative data underlying all
panels are provided in S1 Data, and details of MiSeq libraries including SRA accessions are provided in S2 Data. Cas9, CRISPR-associated protein 9;
eGFP, enhanced green fluorescent protein; sgRNA, single guide RNA; SRA, Sequence Read Archive; ssODN, single-stranded oligodeoxynucleotide.
https://doi.org/10.1371/journal.pbio.2005595.g005
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varied by up to 3-fold between loci. This suggests that DNA sequence features of the target and
HDR template molecules [5,39] are more important than epigenetic properties in determining
HDR efficiency. It is important to stress that our assay is designed to detect DNA sequence
changes rather than DSB repair and cannot, in its current form, measure nonmutagenic repair
that does not lead to genome edits (see Discussion). Nonetheless, the data suggest that the rela-
tive frequency of InDels versus HDR-derived edits, a key parameter in genome editing experi-
ments, is not substantially affected by the preexisting state of local chromatin. We note that a
recent study in Drosophila found that DSB repair kinetics and pathway choice were similar in
euchromatin versus heterochromatin following I-SceI cleavage [40].
Next, we asked whether chromatin modifications influenced the spectrum and frequency
of different InDel mutation classes produced via NHEJ. In line with a recent large-scale deep
sequencing study of InDels induced by Cas9 in cancer cell lines [24], we found that each
sgRNA produced its own characteristic InDel pattern, with the top five recurrent mutations
Fig 6. The ratio of InDels to precise sequence edits is unaffected by heterochromatin. (A) The relative frequency of mutations arising from
NHEJ versus HDR in cells collected at 96 hours post transfection for five sgRNAs with target sites within imprinted heterochromatin (S1A, S2A and
S3A Figs). The percentage of hypermethylated (>80%) strands in mock-transfected cells is indicated above the plot. Asterisk denotes Bonferroni-
corrected p< 0.05 from paired t tests of difference between HDR frequencies on maternal versus paternal alleles. (B) The size and frequency of the
top five most common InDels 96 hours following transfection with sgKVDMR#1 (S1A Fig), broken down by parental allele. The horizontal red line
denotes the predicted cleavage site. Deletion sizes are depicted against the scale bar at the top, and for insertions, the number of inserted bases is
indicated next to the blue rectangle. Note that different +1 nucleotide insertions were observed and are represented as blue rectangles on opposite
sides of the cleavage site. The fraction of Indels was calculated as the number of reads corresponding to each specific mutation expressed as a
proportion of all InDel-containing reads. Quantitative data underlying both panels are provided in S1 Data, and details of MiSeq libraries including
SRA accessions are provided in S2 Data. HDR, homology-directed repair; InDel, Insertion or deletion; mat, maternal; NHEJ, nonhomologous end
joining; PAM, protospacer adjacent motif; pat, paternal; sgRNA, single guide RNA; SRA, Sequence Read Archive.
https://doi.org/10.1371/journal.pbio.2005595.g006
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comprising 30% to 60% of all sequencing reads in cells collected 96 hours following transfec-
tion (Fig 4D, S5 Fig). The same mutations recurred on maternal and paternal chromosomes
(Fig 4D, S5 Fig) despite these allelic target sites starting in very different epigenetic states (Fig
1C and 1D, S1, S2 and S3 Figs). Thus, neither the relative frequency of InDels versus HDR
edits nor the spectrum of different InDels is substantially affected by the presence of hetero-
chromatin at a CRISPR target site.
Discussion
In this study, we have used the classical epigenetic model system of genomic imprinting to
determine the effect of chromatin context on CRISPR-Cas9 genome editing. This internally
controlled approach allowed us to identify key experimental parameters (intracellular Cas9
expression level and duration of exposure) that determine the extent to which repressed chro-
matin impairs mutagenesis. Our findings are consistent with and extend those of previous
studies in this area. The inhibitory effect of nucleosomes on Cas9 binding and cleavage is
well established [7,8,11], and the sgRNAs used in this study targeted regions of allele-specific
DNAse hypersensitivity (S1B, S2B and S3B Figs). On hypersensitive alleles, nucleosome–DNA
interactions are less stable due to chromatin remodelling activities associated with RNA Poly-
merase II transcription [41]. It is also possible that DNA methylation can directly influence
Cas9 binding and/or cleavage, and future studies will be required to address this possibility in
vitro.
We propose that the dynamic nature of chromatin at these sites would provide more oppor-
tunities for Cas9 complexes to bind and cleave their targets per unit of time. Conversely, muta-
tions accumulate more slowly in heterochromatin, where nucleosomes marked by H3K9me3
and H4K20me3 more effectively occlude Cas9 complexes during the target search [9]. Muta-
genesis still occurs within heterochromatin, albeit at a slower rate, presumably due to residual
nucleosome breathing [11] and remodelling associated with DNA replication. Future experi-
ments should focus on post-mitotic cells, both to determine whether heterochromatin exerts
a greater effect on mutagenesis in the absence of DNA replication as well as to remove the
potentially confounding effect of cell cycle stage on DNA repair outcome [42].
Elevated concentrations of Cas9 increase the likelihood of mutation through mass action:
an effect that we observed in both heterochromatin and euchromatin (Fig 4), and which
caused mutagenesis to reach saturation more rapidly. Under conditions of low Cas9 expres-
sion and brief exposure in which no LOI occurred (Fig 1D), heterochromatin impeded muta-
genesis by more than 6-fold (S4 Fig). In practical terms, our findings suggest that chromatin
state is a particularly important consideration during procedures in which the level of Cas9
exposure is kept low. This would be relevant in a clinical setting, in which it is desirable to min-
imise exposure in order to avoid undesirable off-target mutations [43].
We also addressed, to our knowledge for the first time, whether local chromatin state influ-
ences the relative frequency of precise CRISPR-Cas9 genome edits (i.e., templated from exoge-
nous single-stranded donor DNA) versus InDels. We found that this important aspect of
genome editing was not significantly different between heterochromatin and euchromatin.
This is somewhat surprising in light of prior reports that chromatin modifications influence
DSB repair pathway choice in other contexts [20,21,44]. However, our study differs from these
prior reports in several important ways. Firstly, we used Cas9 to introduce DSBs rather than
restriction enzymes or ionising radiation. It is possible that localised chromatin remodelling
events associated with Cas9 binding [16,17] are sufficient to overcome any prior differences
in chromatin state at imprinted loci, which might otherwise influence the outcome of DNA
repair. Secondly, it has been suggested that the repair of Cas9-derived DSBs could occur with
Heterochromatin delays CRISPR mutagenesis
PLOS Biology | https://doi.org/10.1371/journal.pbio.2005595 December 12, 2018 11 / 22
unusually slow kinetics [45], possibly due to the presence of an R-loop proximal to the broken
ends. Caution should therefore be exercised when generalizing findings from Cas9-induced
breaks to those arising from other sources. Thirdly, our assay was designed to quantify genome
editing rather than DSB repair and fails to report on nonmutagenic breaks repaired via NHEJ
without end resection [46] or homologous recombination from the sister chromatid. Although
our data show that the preexisting chromatin status does not affect the spectrum of mutations
induced during genome editing, we emphasise that they do not directly assess the influence of
chromatin on repair pathway choice.
In summary, we show that allele-specific epigenetic model systems such as genomic
imprinting can provide new insights into mechanisms of genome editing in a physiological
setting. Given the expanding range of synthetic DNA binding proteins now used in research,
biotechnology, and medicine [47–51], this approach can provide further insights into their
mode of interaction with chromatin in vivo. A strength of our assay is that it allows the influ-
ence of chromatin modifications to be assessed independently from the underlying DNA
sequence. However, it is important to keep in mind that imprinted heterochromatin spans
small genomic distances (approximately 2–10 kb) and is embedded within genomic euchro-
matin [26], similar to dispersed transposon sequences. Most genomic heterochromatin is
assembled upon larger regions of clustered repeats such as pericentromeres and telomeres, in
which the unusual DNA sequence properties are likely to influence target recognition and
repair independently of chromatin status. Whether mechanisms of genome editing within
imprinted heterochromatin reflect those in pericentromeric regions [52] therefore remains to
be seen. In the future, it will be of interest to extend this study to assess other allele-specific
chromatin states, such as transcribed versus nontranscribed imprinted gene bodies, and targets
on the active versus inactive X chromosome.
Materials and methods
Ethics statement
Institutional Review Board approval for the usage of C57BL6/J and JF1 mice was obtained
from the Reseaux Animalerie de Montpellier, Montpellier, France.
Cell culture and transfection
Hybrid mESCs were derived in serum-free (2i) medium with LIF, Mek inhibitor PD0325901
(1 μM), and Gsk3 inhibitor CHIR99021 (3 μM) as described previously [53] and were main-
tained in ESGRO 1i medium (LIF and Gsk3 inhibitor; Millipore, SF001-500P). Unless
otherwise indicated, all experiments were performed on cells at passages 5–12. A modal
chromosome number of 40 was confirmed by counting metaphase chromosomes of cells at
passage 11.
To derive high-passage cells with reduced CpG methylation at imprinted regions, B×J cells
were cultured to passage 9 under 1i conditions before being switched into 2i medium for an
additional 11 passages with daily media changes. From passages 20–22, ascorbic acid was
added to the 2i media at a concentration of 100 μg/mL, then cells were moved back into
ESGRO 1i medium for a single passage prior to transfection at passage 23.
Protospacer sequences were selected using the online tool hosted by the Broad Institute
(https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design) within three loci
previously described in the literature to exhibit allele-specific CpG methylation [54]. In all
editing experiments, Streptococcus pyogenes Cas9 and sgRNA were both expressed from the
same plasmid. pSpCas9(BB)-2A-GFP (PX458; Addgene plasmid #48138) and pSpCas9(BB)-
2A-Puro (PX459; version 2.0; Addgene plasmid #62988) were gifts from Feng Zhang [35].
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Plasmids were transfected together with a 150-nucleotide ssODN which served as a template
for HDR. ssODNs introduced nucleotide substitutions that removed the NGG protospacer
adjacent motif (PAM) to prevent further cleavage. For the experiments presented in Figs 4 and
5G and S4 Fig, sgRNA and Cas9-2A-eGFP were expressed from plasmid backbone pX458,
whereas all other experiments used plasmid backbone pX459v2 [35]. Sequences of guides and
donor oligonucleotides are listed in S3 Data. Transfections were performed in duplex, i.e.,
each transfection mix contained two separate plasmids encoding sgRNA and ssODNs to
target two loci simultaneously. Experiments examining the effect of Cas9 expression level on
mutagenesis (Figs 4 and 5G and S4 Fig) were the exception; here, plasmids were transfected
individually.
Approximately 16 hours before transfection, 3 × 105 cells were seeded in each well of a
6-well plate. Transfections were conducted using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s protocol, with the following modification: transfection mix comprised a
total of 3 μg plasmid and 150 ng oligonucleotide donor in 10 μL of P2000 reagent. Transfection
efficiencies ranged from 15% to 50%. For all editing experiments that did not involve time
points or Cas9-2A-eGFP selection, successfully transfected cells were selected in medium con-
taining puromycin (1.6 μg/mL) 24 hours following transfection. Puromycin was washed out
together with dead cells at 48 hours following transfection; then, genomic DNA was harvested
from pooled cells at 96 hours. For the experiments in Figs 4 and 5G and S4 Fig, cells were
FACS purified using the gating strategy shown in Fig 4B at 24 hours following transfection.
Each sorted population was split 50:50, with half harvested immediately and the remainder
after an additional 72 hours in culture. Transfected cells were not selected during any of the
time course experiments presented in Fig 5. Sequences of guides and donor oligonucleotides
are listed in S3 Data.
Locus-specific amplification and MiSeq library preparation
DNA was isolated from edited cells using the DNeasy Blood and Tissue Kit (Qiagen) with
RNAse treatment according to the manufacturer’s protocol. Each biological replicate used 50
ng of template DNA, corresponding to 8,333 diploid genomes. Adaptors and barcodes neces-
sary for multiplexed high-throughput amplicon sequencing were added using a two-round
PCR procedure. In the first round, locus-specific primers were designed to span regions
encompassing both the editing site and an allelic SNP, which allowed the origin of each
sequence read to be traced to the maternal or paternal allele. First-round primers contained 50
extensions with a random hexamer, binding sites for Illumina sequencing primers, and bind-
ing sites for universal primers necessary for the second round of cycling. Edited loci were
amplified for 25 cycles using High Fidelity Phusion Polymerase (NEB). PCR products were
purified using AMPure beads (Beckman Coulter) according to the manufacturer’s instructions
and eluted in 50 μL. A total of 10 μL of eluate was taken forward to a second round of PCR for
eight cycles. The second round of PCR used universal primers that contained unique indices
based on the i5 and i7 sequences from the Nextera library prep kit (Illumina). This enabled
multiplexing of libraries on a single flow cell. Locus-specific and universal primer sequences
are listed in S3 Data. Amplified products were purified using AMPure beads and eluted in
25 μL, and then concentration and product size were verified on an Agilent Bioanalyser.
Libraries were pooled at equimolar ratio and run on an Illumina MiSeq to obtain 150 bp
paired-end reads. Sequence data have been deposited at the Sequence Read Archive (SRA)
under project accession PRJNA421037. Individual library details including read numbers are
listed in S1 Data.
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Bisulphite sequencing
DNA was purified from unedited control cells harvested at equivalent passage number to
edited populations (passage 6–12, unless otherwise stated) using the DNeasy Blood and Tissue
Kit (Qiagen). A total of 0.5 μg of DNA was subjected to bisulphite conversion using the EZ
DNA methylation kit (Zymo) according to the manufacturer’s instructions. Each converted
sample was eluted in a 10 μL volume, of which 2 μL was used as a PCR template. The genera-
tion of libraries for Illumina sequencing proceeded as described above with the following
modifications: the first round of PCR comprised 35 cycles rather than 25, and GoTaq Green
(Promega) was used in place of Phusion Taq polymerase. A single library was generated for
each locus.
ChIP
The H3K9me3 ChIP-Seq track (GSM1000147) shown in Fig 1B and S1A Fig is from the
ENCODE mESC line BRUCE4 (C57BL/6J strain), visualised using the UCSC genome browser
on GRC37/mm9. All histone modification ChIP assays presented in Fig 1, S1, S2 and S3 Figs
were performed on the hybrid mESC lines used for mutagenesis studies. H3K9me3 (07–442,
batch 2664282) and H4K20me3 (07–643, batch 2586586) antibodies used in ChIP experiments
were purchased from Millipore. Approximately 1 × 107 cells were harvested at approximately
80% confluency, trypsinised, and washed in ice-cold phosphate buffered saline (PBS). Follow-
ing centrifugation at 500 g, cells were resuspended in 1 mL of ice-cold NBA buffer (85 mM
NaCl, 5.5% sucrose, 10 mM Tris-HCl [pH 7.5], 0.2 mM EDTA, 0.2 mM PMSF, 1 mM DTT,
protease inhibitors). A total of 1mL of NBB buffer (NBA buffer with 0.1% NP-40) was added,
and cells were incubated for 5 minutes on ice, then centrifuged at 1,000 g for 5 minutes at 4
˚C. The pellet was resuspended in 200 μL of NBR buffer (85 mM NaCl, 5.5% sucrose, 10 mM
Tris-HCl [pH 7.5], 3 mM MgCl2, 1.5 mM CaCl2, 0.2 mM PMSF, 1 mM DTT) and centrifuged
for an additional 5 minutes at 4 ˚C, then resuspended in 600 μL NBR buffer. A total of 10 μLL
of RNAseA (10 mg/mL) was added and incubated for 5 minutes at room temperature. A total
of 40 Boehringer units of MNase (Sigma) were added, mixed by pipetting, and incubated at 20
˚C for 10 minutes, with an additional mix by pipetting after 5 minutes. Digestion was stopped
by adding 600 μL of MNase stop buffer (215 mM NaCl, 10 mM Tris-HCl [pH 8], 20 mM
EDTA, 5.5% sucrose, 2% TritonX100, 0.2 mM PMSF, 1 mM DTT, 2x PMSF), and samples
were stored at 4 ˚C overnight.
A total of 40 μL of protein A dynabeads (Invitrogen) were used per sample. After prewash
in block solution (0.5% BSA in PBS), beads were mixed with 2.5 μg antibody in 1 mL block
solution, incubated for 2 hours on a rotating wheel at 4 ˚C, and then washed in 200 μL block
solution. Chromatin was centrifuged at 13,000 RPM for 5 minutes at 4 ˚C, and the supernatant
was transferred to a fresh tube with 10% set aside for use as input. The amount of 1 mL of
supernatant was added to the antibody bound beads together with 5 μL of BSA (5 mg/mL)
before incubation at 4 ˚C for 3 hours on a rotating wheel.
Three washes with ChIP-W1 buffer (150 mM NaCl, 10 mM Tris-HCl [pH 8], 2 mM
EDTA, 1% NP40, 1% sodium deoxycholate) were performed in 1 mL volume on a rotating
wheel for 10 minutes at 4 ˚C, followed by 1 wash in TE Buffer at room temperature without
rotation. After the last wash, beads were resuspended in 100 μL of elution solution (0.1 mM
NaHCO3, 1% SDS), vortexed briefly, and incubated at 37 ˚C in a shaking thermomixer at
700 RPM. The pH was adjusted to pH 8 by adding 7 μL of 2M Tris-HCl (pH 6.8). Dynabeads
were removed, and the remaining solution (and input samples) was treated with 20 μg of
proteinase K for 1 hour at 55 ˚C. ChIP and input DNA were purified on Qiagen PCR purifi-
cation columns.
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For dCas9 ChIP, 1.8 × 106 cells were seeded in each of 5 × 10 cm dishes 16 hours before
transfection using Lipofectamine 2000 (Invitrogen). A total of 24 μg of plasmid was transfected
per dish. The dCas9 backbone plasmid pX330A_dCas9-1x4 was a gift from Takashi Yamamoto
(Addgene plasmid #63598) [55]. Cells were crosslinked in 1% formaldehyde at a density of
2 × 106 per mL for 10 minutes, and then glycine (0.125 M final concentration) was added for
an additional 10 minutes. A single wash in ice-cold PBS was followed by incubation in Farn-
ham lysis buffer (5 mM PIPES [pH 8.0], 85 mM KCl, 0.5% NP-40, protease inhibitors), centri-
fugation, and storage of pellets at −80 ˚C. Upon thawing, a single wash in Farnham lysis buffer
was followed by resuspension in RIPA buffer at 1 × 107 cells per mL. Chromatin was sonicated
to a fragment size of approximately 3 to 5 kb.
A total of 40 μL of protein G Dynabeads (Invitrogen) was used per sample. After prewash
in block solution (0.5% BSA in PBS), beads were mixed with 5 ug antibody (Monoclonal
ANTI-FLAG M2, F1804 Sigma) in 1 mL block solution per sample, incubated for 2 hours on a
rotating wheel at 4 ˚C, and then washed in 200 μL block solution. The sonicated mixtures were
spun at 13,000 RPM for 15 minutes at 4 ˚C to remove impurities. The amount of 1 mL from
each sonicated mixture was used for the IP (900 μL to the beads with antibody and 90 μL main-
tained as 10% Input). IP samples were incubated at 4 ˚C for 18 hours on a rotating wheel.
A total of 5 × 1 mL washes with LiCl Wash Buffer (100 mM Tris [pH 7.5], 500 mM LiCl, 1%
NP-40, 0.5% sodium deoxycholate) were performed on a rotating wheel for 5 minutes at 4 ˚C,
followed by 1 wash in TE Buffer at room temperature without rotation. After the last wash,
beads were resuspended in 200 μL of elution solution (0.1 mM NaHCO3, 1% SDS), vortexed
briefly, and incubated for 1 hour at 65 ˚C in a shaking thermomixer at 1,000 RPM. Dynabeads
were removed, and the remaining solution (and input samples) was treated with 20 μg of pro-
teinase K for 30 minutes at 37 ˚C. A total of 40 μg proteinase K was added to each sample, and
these were incubated for 4 to 5 hours at 65 ˚C to complete reversal of cross links. ChIP and
input DNA were purified on Qiagen PCR purification columns.
For relative quantification of ChIP DNA by real-time qPCR, DNA isolated from 10% of
total MNase digested native chromatin was used to generate a standard curve (5-fold dilutions,
from 10% to 0.08% total input) for IP samples. qPCR was performed in triplicate using SYBR
Select mastermix (Applied Biosystems) on a LightCycler 480 II (Roche) with thermal cycling
as follows: Initial Cycle 50 ˚C for 2 minutes and 95 ˚C for 2 minutes, and then 40 cycles of 95
˚C for 15 seconds, 60 ˚C for 50 seconds, and 60 ˚C for 10 seconds with a single acquisition. A
total of 0.5 μL input or ChIP DNA was used in a total reaction volume of 20 μL. For allele-spe-
cific enrichment analysis, regions spanning an allelic SNP were amplified using GoTaq (Pro-
mega), and amplicons were purified using AMPure beads and then subjected to Sanger
sequencing. Primer sequences are listed in S3 Data.
DNase-I accessibility assay
DNAse-I digestion was performed using a published protocol [56] with the following modifi-
cations. A total of 20 × 106 cells were trypsinised and resuspended in 5 mL buffer A (15 mM
Tris-HCl [pH 7.6], 60 mM KCl, 15 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.5 mM spermi-
dine, 0.15 mM spermine). Cells were lysed in the presence of 0.5% (v/v) NP40, and nuclei
were collected by centrifugation (2000 g/5 minutes) and resuspended in 1 mL digestion buffer
(buffer A supplemented with 3 mM CaCl2, 75 mM NaCl). Digestions were carried out at 37 ˚C
with 0–60 units of DNase-I (Sigma) per 100 μL nuclei, for 5 minutes before the reaction was
stopped by the addition of an equal volume of stop buffer (0.1 M NaCl, 0.1% [w/v] SDS, 50
mM Tris-HCl [pH 8.0], 100 mM EDTA). The samples were treated with 2 μg proteinase K at
55 ˚C overnight, and DNA was recovered after extraction with phenol/chloroform and
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precipitation in ethanol. The DNA was then resuspended in TE buffer (10 mM Tris-HCl [pH
8.0], 1 mM EDTA), and concentration was measured using fluorometric quantitation (Qubit).
Digested DNA was amplified for 30 cycles across regions containing an allelic SNP. Amplicons
were purified using AMPure beads and then subjected to Sanger sequencing across regions of
300 to 600 bp spanning an allelic polymorphism. Primer sequences are listed in S3 Data.
Analysis of high-throughput sequencing data
All samples. Reads were de-multiplexed and duplicate read pairs removed by FastUniq
version 1.1 [57], and adaptors were trimmed with TrimGalore version 0.4.1 (https://www.
bioinformatics.babraham.ac.uk/projects/trim_galore/).
Genomic sequencing of edited samples. Trimmed and de-duplicated read pairs were
aligned to mouse genome build GRCm38 using BWA version 0.7.12 [58]. Read pairs were
extracted by the expected genomic region for each experiment and were assigned to the
C57BL/6J or JF1 chromosome based on nucleotide identity at known polymorphic SNPs
(http://molossinus.lab.nig.ac.jp/msmdb/index.jsp). Read pairs containing mutations originat-
ing from HDR were identified based on the expected sequence changes introduced from the
oligonucleotide donors (S3 Data), whereas read pairs containing InDels within 10 bp of the
cleavage site were identified as originating from fragments that had undergone NHEJ. Read
pairs with evidence of neither were labelled as wild type. Indel length and type (insertion or
deletion) were extracted from the NHEJ read pairs via a custom Perl script.
Bisulphite sequencing of unedited samples. Trimmed and de-duplicated read pairs were
aligned to the bisulphite conversion indexed mouse genome build GRCm38 using Bismark
version 0.16.3 [59] with Bowtie version 2.2.6 [60]. Read pairs that did not align were then sepa-
rated, and each end of the pair was aligned as single end reads. The three resulting alignments
were merged. Read pairs were extracted by the expected genomic region for each experiment.
The number of methylated CpGs in each read pair was counted using a custom Perl script
examining the XM tag for each read in the relevant BAM file. Because not all sequencing
amplicons contained an informative SNP to distinguish parental alleles, we report total meth-
ylation levels across both alleles and do not distinguish maternal from paternal strands. All
sequencing data have been deposited in the SRA under project accession PRJNA421037.
Supporting information
S1 Fig. Allele-specific chromatin states at the imprinted KvDMR locus. (A) UCSC screen
drop showing the KvDMR locus, including the transcriptional start site for the Kcnq1ot1 non-
coding RNA, which is active from the paternal allele. H3K9me3 ChIP and DNase-I–seq data
from mESCs are available through EncODE (ENCSR000CFZ, GSM1014187). Positions of
sgRNA target sites and PCR amplicons used during the analysis are indicated. B. Allele-specific
DNase-I sensitivity of regions indicated in panel A. Note that Target 2 is within an annotated
DNase-I hypersensitive site, whereas Target 1 is not. mESC nuclei were subjected to digestion
with increasing concentrations of DNase-I for 5 minutes at 37 ˚C, before DNA extraction and
Sanger sequencing across SNPs to reveal allele-specific differences in digestion at the regions
indicated in panel A. (C) Native ChIP enrichment for H3K9me3 and H4K20me3 marks at
regions corresponding to sgRNA target site 1, and 2&3 (amplicons indicated in panel A).
Enrichments are expressed relative to input, and error bars represent SD of three technical rep-
licates. qPCR primers spanning Intracisternal A particle (IAP) retrotransposons and the actb
promoter serve as positive and negative controls, respectively. D. Allele-specific enrichment in
ChIP DNA for the Target 1 region shown in panel A determined by RFLP analysis. The data
are representative of two biological replicates for each mESC line. Quantitative data underlying
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panel C are provided in S1 Data, and details of MiSeq libraries including SRA accessions are
provided in S2 Data. SRA, Sequence Read Archive.
(TIF)
S2 Fig. Allele-specific chromatin states at the imprinted Impact locus. (A) UCSC screen
drop showing the transcriptional start site for the Impact gene, which is active from the pater-
nal allele. H3K9me3 ChIP and DNase-I–seq data from mESCs are available through EncODE
(ENCSR000CFZ, GSM1014187). Positions of the sgRNA target site and PCR amplicons used
during the analysis are indicated. (B) Allele-specific DNase-I sensitivity for a region spanning
the target site, as indicated in panel A. (C) ChIP enrichment for H3K9me3 and H4K20me3
marks at the Impact sgRNA target site. Enrichments are presented in the same manner as S1C
Fig. (D) Allele-specific enrichment of ChIP DNA at the Impact sgRNA target site determined
by Sanger sequencing from ChIP DNA across an allelic SNP. ChIP experiments are represen-
tative of two biological replicates for each mESC line. (E) CpG methylation at the Impact pro-
moter presented as described for Fig 1D. The black dashed line indicates the expected level of
methylation across all alleles when imprinting is completely maintained. (F) Allele-specific
mutation analysis from experiments using sgImpact in cells collected 96 hours post transfec-
tion. Data are presented as described in Fig 2. Error bars depict SD, n = 3 biological replicates.
Quantitative data underlying panels C, E, and F are provided in S1 Data, and details of MiSeq
libraries including SRA accessions are provided in S2 Data. SRA, Sequence Read Archive.
(TIF)
S3 Fig. Allele-specific chromatin states at the imprinted Inpp5f_v2 locus. (A) UCSC screen
drop showing the transcriptional start site for the Inpp5f_v2 transcript, which initiates from
the paternal allele. H3K9me3 ChIP and DNase-I–seq data from mouse ESCs available through
EncODE (ENCSR000CFZ, GSM1014187). Positions of the sgRNA target site and PCR ampli-
cons used during the analysis are indicated. (B) Allele-specific DNase-I sensitivity for a PCR
amplicon spanning the Inpp5f_v2 sgRNA target site, as described in S1B Fig. ND = not done
due to poor PCR amplification in these samples. (C) ChIP enrichment for H3K9me3 and
H4K20me3 marks at the Inpp5f_v2 sgRNA target site. Enrichments are presented in the same
manner as S1C Fig. (D) Allele-specific enrichment in ChIP experiments at the Inpp5f_v2
sgRNA target site determined by RFLP analysis of PCR products amplified from ChIP DNA.
ChIP experiments are representative of two biological replicates for each mESC line. (E) CpG
methylation at the Inpp5f_v2 promoter presented as described for Fig 1D. Methylation levels
were measured separately following each transfection; the data shown here are representative.
The black dashed line indicates the expected level of methylation across all alleles when
imprinting is completely maintained. Note the partial LOI that is evident in panels B, D, and
E, particularly in the B×J mESC line. Quantitative data underlying panels C and E are provided
in S1 Data, and details of MiSeq libraries including SRA accessions are provided in S2 Data.
SRA, Sequence Read Archive.
(TIF)
S4 Fig. Heterochromatin impedes mutagenesis in a Cas9-concentration–dependent man-
ner. (A) B×J cells from the transfection shown in Fig 2A were FACS purified according to
the gating scheme shown. Note that this panel depicts the same data shown in panel 2A. (B)
Allele-specific mutation analysis within cell populations expressing different levels of Cas9, as
shown in panel A, FACS purified 24 hours post transfection and then subjected to allele-spe-
cific mutation analysis immediately, without further time in culture. Insufficient J×B cells were
obtained following FACS to assess mutagenesis after 24 hours. (C) Stacked histograms show
the allelic mutation bias in each experimental replicate. Error bars represent SD of three
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biological replicates. A one-way ANOVA was conducted using the fold-difference between
mutation frequencies on maternal versus paternal alleles to determine whether this was
affected by Cas9 expression level. Significant effects were found (p< 0.05). Asterisks denote p-
values for Tukey’s HSD test on the specified pairwise comparisons. �p< 0.05. Quantitative
data underlying panels B and C are provided in S1 Data, and details of MiSeq libraries includ-
ing SRA accessions are provided in S2 Data. SRA, Sequence Read Archive.
(TIF)
S5 Fig. Enhanced Cas9 occupancy in euchromatin compared to heterochromatin. (A) Sche-
matic depicting the experimental workflow for Cas9 ChIP experiments. (B, C) Stacked histo-
grams show ChIP enrichment for dCas9-3xFLAG at regions spanning the sgKvDMR#1 (panel
B) and sgImpact (panel C), expressed relative to input DNA. Overall enrichments were deter-
mined by qPCR, and then separate PCR amplicons were subjected to amplicon deep sequenc-
ing in order to determine the ratio of products from maternal (red) to paternal (blue) alleles.
Each time series was performed once in B×J cells only. Error bars represent SD of overall
recovery from technical triplicate qPCR reactions. Quantitative data underlying panel B are
provided in S1 Data, and details of MiSeq libraries including SRA accessions are provided in
S2 Data. SRA, Sequence Read Archive.
(TIF)
S6 Fig. The same InDel classes recur in heterochromatin and euchromatin 96 hours post
transfection. The size and frequency of the top five most common InDels (broken down by
parental allele) produced by four different sgRNAs targeting imprinted heterochromatin.
Edited genomic DNA was extracted 4 days following transfection with sgRNAs targeting the
KvDMR (panels A and B), Impact (panel C), and Inpp5f_v2 (panel D) imprinted loci in B×J
(left) and J×B (right) cells. Deletion sizes are depicted against the scale bar at the top of each
panel, and the number of inserted bases is indicated next to the blue rectangle. Note that any
of four possible nucleotides can theoretically be inserted; therefore, more than one +1 insertion
was observed in some instances. The horizontal red line denotes the predicted cleavage site,
and the colour key for all panels is situated at the bottom left of the figure. The fraction of
Indels was calculated as the number of reads corresponding to each specific mutation class,
expressed as a proportion of all InDel-containing reads. The fraction of hypermethylated
strands in mock-transfected cells is indicated below each plot. Details of MiSeq libraries
including SRA accessions are provided in S2 Data. SRA, Sequence Read Archive.
(TIF)
S1 Data. Quantitative data underlying summary figures.
(XLSX)
S2 Data. Details of Illumina sequencing libraries used in this study including SRA sample
accessions. SRA, Sequence Read Archive.
(XLSX)
S3 Data. Details of oligonucleotides used in this study.
(XLSX)
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